Literature DB >> 29569482

Classification of miRNA-related sequence variations.

Karin Hrovatin1, Tanja Kunej1.   

Abstract

miRNA regulome is whole set of regulatory elements that regulate miRNA expression or are under control of miRNAs. Its understanding is vital for comprehension of miRNA functions. Classification of miRNA-related genetic variability is challenging because miRNA interact with different genomic elements and are studied at different omics levels. In the present study, miRNA-associated genetic variability is presented at three levels: miRNA genes and their upstream regulation, miRNA silencing machinery and miRNA targets. Several types of miRNA-associated genetic variations are known, including short and structural polymorphisms and epimutations. Differential expression can also affect miRNA regulome function. Classification of miRNA-associated genetic variability presents a baseline for complementing sequence variant nomenclature, planning of experiments, protocols for multi-omics data integration and development of biomarkers.

Keywords:  SNP; epigenomics; expression profile; genetic disease; genetic variability; miRNA; miRNA regulome; miRNA target; silencing machinery; tools for miRNA

Mesh:

Substances:

Year:  2018        PMID: 29569482     DOI: 10.2217/epi-2017-0126

Source DB:  PubMed          Journal:  Epigenomics        ISSN: 1750-192X            Impact factor:   4.778


  10 in total

1.  miR-100 rs1834306 A>G Increases the Risk of Hirschsprung Disease in Southern Chinese Children.

Authors:  Yun Zhu; Ao Lin; Yi Zheng; Xiaoli Xie; Qiuming He; Wei Zhong
Journal:  Pharmgenomics Pers Med       Date:  2020-08-10

Review 2.  The associations and roles of microRNA single-nucleotide polymorphisms in cervical cancer.

Authors:  Yaheng Li; Chuanyin Li; Shuyuan Liu; Jia Yang; Li Shi; Yufeng Yao
Journal:  Int J Med Sci       Date:  2021-04-07       Impact factor: 3.738

3.  TP53 mediated miR-3647-5p prevents progression of cervical carcinoma by targeting AGR2.

Authors:  Ronghua Liu; Min Qian; Ting Zhou; Pengfei Cui
Journal:  Cancer Med       Date:  2019-08-22       Impact factor: 4.452

4.  Identification of a Distinct miRNA Regulatory Network in the Tumor Microenvironment of Transformed Mycosis Fungoides.

Authors:  Cosimo Di Raimondo; Zhen Han; Chingyu Su; Xiwei Wu; Hanjun Qin; James F Sanchez; Yate-Ching Yuan; Xochiquetzal Martinez; Farah Abdulla; Jasmine Zain; Chun-Wei Chen; Steven T Rosen; Christiane Querfeld
Journal:  Cancers (Basel)       Date:  2021-11-22       Impact factor: 6.575

5.  Acetylation of H3K27 activated lncRNA NEAT1 and promoted hepatic lipid accumulation in non-alcoholic fatty liver disease via regulating miR-212-5p/GRIA3.

Authors:  Min-Jie Hu; Mei Long; Rong-Juan Dai
Journal:  Mol Cell Biochem       Date:  2021-10-15       Impact factor: 3.396

6.  MicroRNA editing patterns in Huntington's disease.

Authors:  Shiyong Guo; Jun Yang; Bingbing Jiang; Nan Zhou; Hao Ding; Guangchen Zhou; Shuai Wu; Angbaji Suo; Xingwang Wu; Wenping Xie; Wanran Li; Yulong Liu; Wei Deng; Yun Zheng
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

7.  Transcription Factors and Methylation Drive Prognostic miRNA Dysregulation in Hepatocellular Carcinoma.

Authors:  Shijie Qin; Jieyun Xu; Yunmeng Yi; Sizhu Jiang; Ping Jin; Xinyi Xia; Fei Ma
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

8.  Predicting Associations of miRNAs and Candidate Gastric Cancer Genes for Nanomedicine.

Authors:  Aigul Akimniyazova; Anna Pyrkova; Vladimir Uversky; Anatoliy Ivashchenko
Journal:  Nanomaterials (Basel)       Date:  2021-03-10       Impact factor: 5.076

9.  MicroRNA-Target Interaction Regulatory Network in Alzheimer's Disease.

Authors:  Aleksander Turk; Tanja Kunej; Borut Peterlin
Journal:  J Pers Med       Date:  2021-12-02

10.  Analysis of microRNA processing machinery gene (DROSHA, DICER1, RAN, and XPO5) variants association with end-stage renal disease.

Authors:  Manal S Fawzy; Baraah T Abu AlSel; Eman A Toraih
Journal:  J Clin Lab Anal       Date:  2020-08-07       Impact factor: 3.124

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.